| Health / Medical Topics |
HER-2/neu Intracellular Domain Protein
The cytoplasmic domain or intracellular domain (ICD) of the HER2/neu protein that exhibits tyrosine kinase activity. Based on sensitization theory, co-administration of trastuzumab (anti-HER-2/neu monoclonal antibody) and HER-2/neu intracellular domain protein may result in the potentiation of a HER2/neu-specific cytotoxic T lymphocyte (CTL) response against tumor cells overexpressing the HER2/neu protein. HER-2/neu protein, a glycoprotein cell surface receptor that is composed of an extracellular domain (ECD), a transmembrane domain, and an ICD, is overexpressed by many adenocarcinomas including breast adenocarcinoma. (NCI Thesaurus)
YOU MAY ALSO LIKE
A vaccine comprised of autologous dendritic cells pulsed with HER2/neu intracellular domain protein to induce a T-cell response.
A vaccine comprised of HER-2-neu and carcinoembryonic antigen synthetic (CEA) peptides, combined with the adjuvants granulocyte-macrophage colony stimulating factor (GM-CSF), and Montanide…
A first generation sulfonylurea with antihyperglycemic activity. Heptolamide has never been marketed.
An aliphatic carboxylic acid, also known as enanthic acid, used in the synthesis of esters for products such as fragrances and artificial…
A seven-sided polygon.
A class of monounsaturated fatty acids with 17 carbons.
